Experimental Cholesterol Drug Raises Blood Pressure
NEW YORK (AP) -- Shares of Pfizer Inc., the world's largest drugmaker, slipped Tuesday after early data on its combination cholesterol therapy showed a slight increase in patients' blood pressure even though it had a significant positive effect on cholesterol levels.
PFE closed at 26.60.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment